Reply to the Letter to the Editor 'Neoadjuvant radiochemotherapy and perioperative chemotherapy does not represent a standard at same priority level for oesophageal adenocarcinomas (in regard to "Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up")' by Cellini et al
Annals of oncology.
2023 Jun ;
34 (6) :
554-555.
[epub] 20230505
Language English Country Great Britain, England Media print-electronic
Document type Letter, Comment
Persistent link
https://www.medvik.cz/link/pmid37295906
PubMed
37295906
DOI
10.1016/j.annonc.2023.03.004
PII: S0923-7534(23)00118-7
Knihovny.cz E-resources
- MeSH
- Adenocarcinoma * therapy drug therapy MeSH
- Chemoradiotherapy MeSH
- Humans MeSH
- Esophageal Neoplasms * therapy drug therapy MeSH
- Follow-Up Studies MeSH
- Neoadjuvant Therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
References provided by Crossref.org
